Rebuttal From Dr Suissa
- PMID: 38986637
- DOI: 10.1016/j.chest.2024.03.032
Rebuttal From Dr Suissa
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: S. S. attended scientific advisory committee meetings or received speaking fees from AstraZeneca, Atara, Boehringer-Ingelheim, Bristol-Myers-Squibb, Merck, Novartis, Panalgo, Pfizer, and Seqirus.
Publication types
LinkOut - more resources
Full Text Sources